ArticleJournal of thoracic disease2025
Computed tomography-guided lipiodol marking enables margin-secure wedge resection for colorectal pulmonary metastases.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Achieving adequate surgical margins is crucial in pulmonary metastasectomy for colorectal cancer, but thoracoscopic resection of small, deeply situated lesions is technically demanding. Failure to obtain sufficient margins may increase the risk of local recurrence, especially when wedge resection is performed in patients who often require repeat pulmonary surgery. The aim of this study was to assess whether computed tomography (CT)-guided lipiodol marking facilitates margin-secure wedge resection. Methods: This retrospective cohort study included forty-seven patients (61 nodules <10 mm in diameter or located ≥5 mm from the pleura) who underwent lipiodol marking followed by wedge resection between 2016 and 2023. The primary outcome was a pathologic margin-to-tumor (M/T) ratio ≥1. Multivariable logistic regression with bootstrap validation was used to identify predictors of M/T ratio ≥1. Local recurrence and perioperative complications were also recorded. Results: R0 resection was obtained for all nodules and M/T ratio ≥1 was achieved in 82%. Greater tumor depth [odds ratio (OR) =0.10] and diameter (OR =0.64) were independent predictors of failure to reach M/T ratio ≥1. Local recurrence occurred only in lesions with M/T ratio <1 (36.4%). There were no serious marking-related complications. Conclusions: CT-guided lipiodol marking is safe and enables precise, lung-preserving wedge resection with adequate margins in colorectal lung metastases. These findings support its use as a valuable adjunct in thoracoscopic metastasectomy and highlight the importance of margin assessment in surgical planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.